Skip to content

study on Electroconvulsive Therapy among patients with schizophrenia.

A Comparative Study of Clinical Outcome Between Bifrontal And Bitemporal Electroconvulsive Therapy Among Patients with Schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028562
Enrollment
60
Registered
2020-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia Health Condition 2: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders

Interventions

Intervention1: Electroconvulsive Therapy: Electroconvulsive therapy is one among biological treatments for schizophrenia. Intervention2: ELECTOCONVULSIVE THERAPY: Since its introduction in 1938, Elect

Sponsors

Dr Muhammed Irfan PP
Lead Sponsor
Lokopriya Gopinath Bordoloi Regional Institute of Mental Health
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients fulfilling the ICD-10 criteria for Schizophrenia who are prescribed ECT by treating psychiatrist. b) Patients going to receive a course of electroconvulsive therapy as advised by treating team. c) Patient or Nominated representative of the patient giving informed consent both for ECT and for this study.

Exclusion criteria

Exclusion criteria: a) Substance use disorder in dependence pattern except caffeine and nicotine . b) Patients diagnosed as suffering from major medical or neurological disorder by history or examination or investigation. c) Those patients who received electroconvulsive therapy in previous 6 months. d) Patients with intellectual disability disorder and other comorbid psychiatric illness. e) Catatonia patients f) Patients not amenable for baseline cognitive assessment

Design outcomes

Primary

MeasureTime frame
Clinical Response after ECTTimepoint: after 6 ECT session

Secondary

MeasureTime frame
cognitive adverse effects of bifrontal and bitemporal ECT.Timepoint: after 6 ECTSession.

Countries

India

Contacts

Public ContactDr Muhammed IrfanPP

Gauhati university

drkpathak@gmail.com9435080693

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026